Pharmacokinetic and pharmacodynamic properties of taspoglutide, a once-weekly, human GLP-1 analogue, after single-dose administration in patients with Type 2 diabetes. [electronic resource]
Producer: 20100729Description: 1156-64 p. digitalISSN:- 1464-5491
- Delayed-Action Preparations -- administration & dosage
- Diabetes Mellitus, Type 2 -- drug therapy
- Dose-Response Relationship, Drug
- Double-Blind Method
- Drug Administration Schedule
- Female
- Glucagon-Like Peptide 1 -- administration & dosage
- Humans
- Hypoglycemic Agents -- administration & dosage
- Injections, Subcutaneous
- Male
- Middle Aged
- Peptides -- administration & dosage
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.